Salestools LogoSalestools
Agenti IA Salestools
Soluzioni
Risorse
Azienda
Prezzi
Salestools Logo

Salestools

L'agente IA #1 per team di vendita e Go-to-Market. Vendi di più, più velocemente, con meno sforzo.

Prodotto

  • Agenti di vendita IA
  • Dati di intenzione
  • Dati Tecnologici
  • Tracciamento Visitatori
  • Co-Pilota
  • Vendita Sociale

Soluzioni

  • Servizio Clienti
  • E-commerce
  • SaaS
  • Impresa
  • Piccole Imprese

Risorse

  • Il rapporto
  • Documentazione
  • Riferimento API
  • Centro assistenza
  • Blog
  • Casi studio
  • Webinar

Azienda

  • Chi siamo
  • Carriere
  • Stampa
  • Contatto
  • Partner

Le nostre sedi

  • New York, HQ
  • Bucarest, Laboratorio di Ricerca IA
  • Zug, Svizzera

© 2025 Salestools. Tutti i diritti riservati.

Termini sui Dati e SicurezzaPolitica sulla privacyTermini di servizio
Tutti i sistemi operativi
Salestools LogoSalestools
Agenti IA Salestools
Soluzioni
Risorse
Azienda
Prezzi
Back to The Report
Fundraising

Legal & General

Legal & General Raises $20B in Public

1836
Founded
10000+
Employees
One Coleman Street, London EC2R 5AA, United Kingdom
Updated January 1, 2024
2 min read

Quick Facts

Legal & General Raises $20B in Public


Legal & General has successfully raised $20B in a Public at a $22B valuation led by Public.


Company Overview


Legal & General is a Insurance company headquartered in One Coleman Street, London EC2R 5AA, United Kingdom, founded in 1836 with 10000+ employees.


Financial services company


Fundraising Details


  • Amount Raised: $20B
  • Round Type: Public
  • Valuation: $22B
  • Date: 2024-01-01
  • Investors: Public

About Legal & General


Financial services company The company is positioned in the Insurance sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: One Coleman Street, London EC2R 5AA, United Kingdom
  • Founded: 1836
  • Team Size: 10000+
  • Industry: Insurance

What This Means


This funding round demonstrates strong investor confidence in Legal & General's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Insurance sector continues to attract significant investment as companies innovate to meet evolving market demands. Legal & General's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $22B valuation marks an important milestone for Legal & General, positioning the company among notable players in the Insurance industry.


Looking Ahead


With this new capital, Legal & General is well-positioned to execute on its growth strategy and continue building innovative solutions in the Insurance space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-01. For more information about Legal & General, visit their headquarters at One Coleman Street, London EC2R 5AA, United Kingdom.

Topics

Fundraising(2912)Public(771)InsuranceLegal & General

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million